Ataluren
In vial of 0.5 g net
TargetMol Chemicals Inc.
Product Overview
Product / Grade Name
Ataluren
Maker Name
Product Description
Ataluren (PTC124) is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk.
Hazard Classification
UN Number
:IMGD Class
:Packing Group
:
Visual Overview
Corporate Video